Our identity

Chiesi is an international, research-focused company


Through over 80 years in business, we have established a strong heritage in producing innovative

pharmaceutical solutions to improve the quality of human life. We are committed to delivering outstanding results with integrity, operating in a socially and environmentally responsible manner.

Our mission

Our aim is to be recognised as a research-focused international Group, able to develop and commercialise innovative pharmaceutical solutions to improve the quality of human life.

We wish to maintain a high quality entrepreneurial team characterised by self-confidence and a collaborative spirit.

Our goal is to combine commitment to results with integrity, operating in a socially and environmentally responsible manner.

Vision 2025

By 2025 we aspire to be a point of reference for patients affected by chronic respiratory disorders, rare diseases and other health conditions which are difficult to treat, offering them and those who take care of them innovative solutions in the management of their needs, even exploring new frontiers in treatment and care.

While remaining a family-controlled company, we want to continue to grow ambitiously by focusing on key markets, but also expanding patients’ access to care in key emerging countries. We aim to maintain a profitability level adequate to sustain our investments in innovation, development and internationalization efforts.

We believe we can achieve all this only through teamwork, taking care with particular attention of the wellbeing and the excellence of all the people working with us.


EVERYONE OF US IS CHIES
I

Our culture and values

Applying them on a daily basis in everything we do and in our relationships with employees and partners.

Our strategy

BALANCING GROWTH AND GEOGRAPHY

Our business strategy can be summarised very simply: we aim to continue

growing, while maintaining the right balance of locations and therapeutic

areas.


OUR STRATEGY FOR OUR THERAPEUTIC AREAS

Respiratory therapy is our DNA. It is where the company started, and historically, it has been the key driver for Chiesi’s growth. However, we consider all our therapeutic areas to be equally important, and as we evolve, our strategy is to grow our presence and capabilities in these important areas.


We believe the duty of a market leader is not just to develop drugs, but also to deliver a full range of products, services and devices that support patients, physicians and nurses and improve quality of life.